Evidence map›Paper›PMID 25077106›Full record

ArticleCMAJ open2013

Mortality in a large community-based cohort of inner-city residents in Vancouver, Canada.

Gregory D Deans, Jesse D Raffa, Calvin Lai, Benedikt Fischer, Mel Krajden, Janaki Amin, Scott R Walter, Gregory J Dore, Jason Grebely, Mark W Tyndall

Abstract read
In one paragraph

Article in CMAJ open, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Impact of individualized care on readmissions after a hospitalization for acute exacerbation of COPD.International journal of chronic obstructive pulmonary disease · 2016
    Article
  8. Misplaced advocacy: What does better hepatitis C treatment really mean?CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2015
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gregory D DeansDivision of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC.
Jesse D RaffaDepartment of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ont.
Calvin LaiBritish Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC.
Benedikt FischerCentre for Applied Research in Mental Health and Addiction, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC.
Mel KrajdenBritish Columbia Centre for Disease Control, Vancouver, BC.
Janaki AminThe Kirby Institute for infection and immunity in society, University of New South Wales, Sydney, Australia.
Scott R WalterCentre for Health Systems and Safety Research, Australian Institute of Health Innovation, University of New South Wales, Sydney, Australia.
Gregory J DoreThe Kirby Institute for infection and immunity in society, University of New South Wales, Sydney, Australia.
Jason GrebelyThe Kirby Institute for infection and immunity in society, University of New South Wales, Sydney, Australia.
Mark W TyndallDivision of Infectious Diseases, Department of Medicine, University of Ottawa, Ottawa, Ont.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Downtown Eastside is a robust and densely populated neighbourhood in Vancouver, Canada, that is characterized by low-income housing and drug use and a high prevalence of HIV infection. We evaluated mortality and excess mortality among the broader community of individuals living in this neighbourhood.

methodsThe Community Health and Safety Evaluation is a community-based study of inner-city residents in the Downtown Eastside who were recruited in 2003 and 2004. Participants' data were linked with data in provincial virology and mortality databases retrospectively and prospectively for the period 1991-2009. Mortality and standardized mortality ratios (SMRs) were calculated for the period 2003-2009 to compare death rates in the study population with rates in the population of Vancouver.

resultsAmong 2913 participants, 374 deaths occurred, for an all-cause mortality of 223 per 10 000 person-years (95% confidence interval [CI] 201-247 per 10 000 person-years). Compared with the population of Vancouver, significant excess mortality was observed in the study population (SMR 7.1, 95% CI 6.4-7.9). Excess mortality was higher among women (SMR 15.4, 95% CI 12.8-18.5) than among men (SMR 5.8, 95% CI 5.1-6.6). Although crude mortality increased with age, excess mortality was greatest among participants less than 35 years old (SMR 13.2, 95% CI 9.4-18.5) and those 35-39 years old (SMR 13.3, 95% CI 10.3-17.1). Excess risk was also elevated among participants with hepatitis C virus (HCV), HIV and HCV/HIV infection, with SMRs of 5.9 (95% CI 4.9-7.1), 19.2 (95% CI 12.8-28.9) and 23.0 (95% CI 19.3-27.4), respectively.

interpretationOur study showed high mortality in this inner-city population, particularly when compared with the general population of Vancouver. Excess mortality was highest among women, younger participants and those infected with either HCV or HIV or both.

Identifiers

PMID25077106
PMCPMC3985976

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.